Table 5.
Cas9 | Cas9ΔNT1 | LmexΔNT1+TcrNT2 | ||||
---|---|---|---|---|---|---|
EC50 (μM) | EC50 (μM) | EC50 (μM) | Sensitization (fold) | p vs. Cas9ΔNT1 | ||
Tubercidin | 1.02 ± 0.16 | 25.7 ± 0.94 | 0.82 ± 0.13 | 31.2 | <0.001 | |
1 (FH11706) | >100 | >100 | ND | |||
2 (FH10714) | >100 | >100 | >100 | |||
TH1012 | 52.5 ± 0.3 | 280 ± 18 | 96.6 ± 0.3 | 2.9 | <0.001 | |
FH3147 | 8.41 ± 1.61 | >100 | 13.7 ± 1.25 | 7.3 | <0.001 | |
FH3169 | 0.24 ± 0.06 | 2.00 ± 0.19 | 0.32 ± 0.05 | 6.3 | <0.01 | |
TH1004 | 37.0 ± 0.23 | 138 ± 10 | 101 ± 0.5 | 1.37 | <0.05 | |
3 (FH8513) | >100 | 100.5 ± 0.9 | 31.1 ± 0.5 | 3.2 | <0.01 | |
Pentamidine | 0.87 ± 0.10 | 1.25 ± 0.22 | 1.12 ± 0.17 | 1.11 | >0.05 |
EC50, 50% effective concentration determined in a resazurin-based assay; sensitization is determined as the ration of the EC50 values of the Cas9ΔNT1 and Cas9ΔNT1+TcrNT2 strains. The p value is based on an unpaired, two-tailed Student’s t-test comparing the EC50 values of the same two strains (n ≥ 3).